High GFAP expression notably upregulated pathways related to riboflavin metabolism, O-glycan biosynthesis, and taurine and hypotaurine metabolism, while downregulating primary immunodeficiency, basal cell carcinoma, and maturity-onset diabetes of the young. This evidence concerns the gene GFAP and type 2 diabetes mellitus.